1. Home
  2. ALLR vs GXAI Comparison

ALLR vs GXAI Comparison

Compare ALLR & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • GXAI
  • Stock Information
  • Founded
  • ALLR 2004
  • GXAI 2021
  • Country
  • ALLR United States
  • GXAI United States
  • Employees
  • ALLR N/A
  • GXAI N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • GXAI
  • Sector
  • ALLR Health Care
  • GXAI
  • Exchange
  • ALLR Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • ALLR 2.3M
  • GXAI 2.5M
  • IPO Year
  • ALLR N/A
  • GXAI 2023
  • Fundamental
  • Price
  • ALLR $1.32
  • GXAI $1.41
  • Analyst Decision
  • ALLR
  • GXAI
  • Analyst Count
  • ALLR 0
  • GXAI 0
  • Target Price
  • ALLR N/A
  • GXAI N/A
  • AVG Volume (30 Days)
  • ALLR 658.4K
  • GXAI 3.7M
  • Earning Date
  • ALLR 11-14-2024
  • GXAI 11-26-2024
  • Dividend Yield
  • ALLR N/A
  • GXAI N/A
  • EPS Growth
  • ALLR N/A
  • GXAI N/A
  • EPS
  • ALLR N/A
  • GXAI N/A
  • Revenue
  • ALLR N/A
  • GXAI $2,979.00
  • Revenue This Year
  • ALLR N/A
  • GXAI N/A
  • Revenue Next Year
  • ALLR N/A
  • GXAI N/A
  • P/E Ratio
  • ALLR N/A
  • GXAI N/A
  • Revenue Growth
  • ALLR N/A
  • GXAI N/A
  • 52 Week Low
  • ALLR $1.26
  • GXAI $1.25
  • 52 Week High
  • ALLR $666.00
  • GXAI $19.20
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 32.39
  • GXAI 46.13
  • Support Level
  • ALLR $1.32
  • GXAI $1.37
  • Resistance Level
  • ALLR $1.53
  • GXAI $2.49
  • Average True Range (ATR)
  • ALLR 0.12
  • GXAI 0.15
  • MACD
  • ALLR 0.05
  • GXAI 0.03
  • Stochastic Oscillator
  • ALLR 14.63
  • GXAI 6.90

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: